MyAverix Finance
HK · Healthcare
CARsgen Therapeutics Holdings Ltd (2171)
Biotechnology
CARsgen Therapeutics Holdings Ltd (2171) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $9.56B, P/E ratio is 18.00, net margin is -77.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2171
CARsgen Therapeutics Holdings Ltd (2171) — FAQ
What is CARsgen Therapeutics Holdings Ltd's market cap?
CARsgen Therapeutics Holdings Ltd (2171) has a reported market cap of $9.56B (data as of 2026-05-21).
What is 2171's P/E ratio?
The price-to-earnings (P/E) ratio for CARsgen Therapeutics Holdings Ltd (2171) is 18.00 (data as of 2026-05-21).
Does CARsgen Therapeutics Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for CARsgen Therapeutics Holdings Ltd (2171). Check the MyAverix Finance app for the latest dividend data.
What sector is CARsgen Therapeutics Holdings Ltd in?
CARsgen Therapeutics Holdings Ltd (2171) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2171 listed on?
2171 is listed on HK.
What is CARsgen Therapeutics Holdings Ltd's net margin?
CARsgen Therapeutics Holdings Ltd (2171) reports a net margin of -77.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.